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With Deterioration of Left Ventricular Systolic
Function in Chronic Chagas’ Cardiomyopathy
Fla´vio C. Hiss, MD, Thiago F. Lascala, MD, Benedito C. Maciel, MD, PHD,
José A. Marin-Neto, MD, PHD, FACC, Marcus V. Simões, MD, PHD
São Paulo, Brazil
O B J E C T I V E S This study aimed at analyzing the association between myocardial perfusion changes
and the progression of left ventricular systolic dysfunction in patients with chronic Chagas’ cardiomy-
opathy (CCC).
B A C KG ROUND Pathological and experimental studies have suggested that coronary microvas-
cular derangement, and consequent myocardial perfusion disturbance, may cause myocardial damage
in CCC.
METHOD S Patients with CCC (n  36, ages 57  10 years, 17 males), previously having undergone
myocardial perfusion single-positron emission computed tomography and 2-dimensional echocardiog-
raphy, prospectively underwent a new evaluation after an interval of 5.6  1.5 years. Stress and rest
myocardial perfusion defects were quantiﬁed using polar maps and normal database comparison.
R E S U L T S Between the ﬁrst and ﬁnal evaluations, a signiﬁcant reduction of left ventricular ejection
fraction was observed (55  11% and 50  13%, respectively; p  0.0001), as well as an increase in the
area of the perfusion defect at rest (18.8  14.1% and 26.5  19.1%, respectively; p  0.0075). The
individual increase in the perfusion defect area at rest was signiﬁcantly correlated with the reduction in
left ventricular ejection fraction (R  0.4211, p  0.0105). Twenty patients with normal coronary arteries
(56%) showed reversible perfusion defects involving 10.2  9.7% of the left ventricle. A signiﬁcant
topographic correlation was found between reversible defects and the appearance of new rest perfusion
defects at the ﬁnal evaluation. Of the 47 segments presenting reversible perfusion defects in the initial
study, 32 (68%) progressed to perfusion defects at rest, and of the 469 segments not showing
reversibility in the initial study, only 41 (8.7%) had the same progression (p  0.0001, Fisher exact test).
CONC L U S I O N S In CCC patients, the progression of left ventricular systolic dysfunction was
associated with both the presence of reversible perfusion defects and the increase in perfusion defects
at rest. These results support the notion that myocardial perfusion disturbances participate in the
pathogenesis of myocardial injury in CCC. (J Am Coll Cardiol Img 2009;2:164–72) © 2009 by the
American College of Cardiology Foundation
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165hronic Chagas’ cardiomyopathy (CCC) is
a serious public health problem on the
Latin American subcontinent, represent-
ing one of the major causes of heart failure
nd sudden death in many regions (1). The slow
rogression of myocardial damage occurs over a
rolonged period of 2 to 3 decades. During the
ore advanced phases of the disease, there is an
ntense dilation of all cardiac chambers and severe
ystolic dysfunction of both ventricles that associ-
tes with heart failure, malignant ventricular ar-
hythmia, and thromboembolic phenomena (2).
espite the high morbidity and mortality associated
ith CCC, its pathogenesis is still poorly under-
tood (3).
See page 173
It is believed that myocardial damage is mainly
ependent on parasitism of myocardial fibers by
rypanosoma cruzi and aggression of nonparasitized
issue by an autoimmune reaction. In addition,
everal lines of evidence, including autopsy studies
n humans (4,5) and experimental investigations
6,7), suggest that derangements of the coronary
icrocirculation may impair regional myocardial
erfusion, producing myocytolysis and reparative
brosis (3).
In agreement with this hypothesis, several clinical
tudies using myocardial perfusion scintigraphy
ave demonstrated a high prevalence of reversible
erfusion defects in patients with CCC in the
resence of angiographically normal subepicardial
oronary arteries, suggesting the presence of abnor-
alities in the regulation of myocardial blood flow
t the coronary microvascular level (8,9).
In a recent study of patients with CCC, we
emonstrated a positive correlation between the
xtent of perfusion defects and the severity of left
entricular (LV) systolic dysfunction. In that study,
eversible perfusion defects were detected in a
izable proportion of patients with early stages of
hagas’ disease and normal LV systolic function
10). These data support the hypothesis that
hanges in myocardial perfusion may precede the
nset of ventricular dysfunction and may participate
n the pathogenesis of Chagas’ cardiomyopathy.
owever, no longitudinal study has been conducted
hus far to test this hypothesis.
Therefore, the objective of the present study
as to investigate the correlation of progressive
hanges in myocardial perfusion at rest and dur-
ng stress with the impairment of regional and plobal LV systolic function in patients with CCC
nd angiographically normal subepicardial coro-
ary arteries.
E T H O D S
tudy population. The study was conducted on 36
ubjects with Chagas’ disease being followed up at
he outpatient clinics of the Cardiology Division,
niversity Hospital, Medical School of Ribeirão
reto. The only inclusion criteria were to have a
ositive epidemiology and serologic tests for T.
ruzi infection, and to have undergone myocardial
erfusion scintigraphy and a 2-dimensional echo-
ardiogram (ECG) at least 2 years before enroll-
ent in the study.
Exclusion criteria were pregnancy, unstable clin-
cal condition, or presence of comorbidities that
ight be associated with microvascular disease,
uch as diabetes mellitus, hypertension, cardiac
alvular disease, history of obstructive coronary
rtery disease, and other forms of cardio-
yopathy.
After enrollment, all patients had a full
linical and laboratory evaluation including a
tandard 12-lead resting ECG, a resting
ransthoracic 2-dimensional ECG, and a
ew scintigraphic study of myocardial per-
usion at rest and under stress. The results
btained during this late phase of evalua-
ion were compared with those obtained at
he initial evaluation. The mean interval
etween the 2 evaluations was 5.6  1.5
ears.
Twenty of the 36 patients showed reversible
erfusion defects and underwent coronary angiog-
aphy, which ruled out the presence of obstructive
oronary artery disease of subepicardial vessels.
The study was conducted according to the pre-
epts of the Helsinki Declaration and was approved
y the Research Ethics Committee of our institu-
ion. All patients gave written informed consent to
articipate.
yocardial perfusion scintigraphy. The scintigraphic
tudies were performed using a digital DST camera
Sopha Medical Vision, Twinsburg, Ohio) equipped
ith a double detector, a wide rectangular view
eld, a dedicated processor (NXT-P, Sopha Med-
cal Vision), and low-energy and high-resolution
ollimators.
The single-positron emission computed tomog-
aphy (SPECT) images were acquired with the
A B B
A N D
CCC
cardio
ECG
LV
LVEF
fractio
SPECT
compatient in the supine position, with a semicR E V I A T I O N S
A C R O N YM S
chronic Chagas’
myopathy
electrocardiogram
left ventricular
 left ventricular ejection
n
 single-photon emissionircular
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166rbit (from the right anterior oblique projection to
he left posterior oblique projection), at 180°, in 32
rojections, 60 s/projection. Symmetric 20% energy
indows centered on the energy peak were used for
he 2 isotopes employed, namely, thallium-201 (70
eV) and technetium-99m (140 keV). Acquisition
atrices of 64  64 pixels were used, with a pixel
ize of 0.6 cm. The tomographic images were
orrected for field uniformity and center of rotation.
All anti-ischemic medications were discontinued
or 48 h before the study. Exercise treadmill (n 
1) or vasodilating stimulation with dipyridamole
n  25) was used as the stress test. Sestamibi-
c99m and thallium-201 were used as radiotracers
f regional myocardial blood flow. The imaging
rotocol with sestamibi-Tc99m included the injec-
ion of 12 to 15 mCi at rest and 25 to 30 mCi at the
eak of stress 3 to 4 h later, with the images being
cquired 60 min after injection of the radiopharma-
eutical. The protocol for thallium-201 consisted of
njections of 3 to 4 mCi at the peak of stress, with
mage acquisition within 10 min, followed by re-
istribution images 3 to 4 h afterward.
rocessing and analysis of the scintigraphic images. To-
ographic sections on the 3 orthogonal planes were
alculated according to the axis of the heart. Polar
aps were constructed by using commercially avail-
ble software (MyoQuant Liege, Sopha Medical
ision). The left ventricular surface was divided
nto 17 segments for the analysis of myocardial
erfusion and used for correlation with the visual
nalysis of segmental regional mobility in the echo-
ardiographic study.
Quantitative analysis was carried out by compar-
ng the polar maps of the patients with a data bank
or normal persons under the same physiological
onditions (rest/stress) and for sex and isotope used
technetium-99m or thallium-201). Myocardial re-
ions showing uptake values below 2.5 SD in
elation to the mean value for normal subjects were
dentified as uptake defects.
For each image obtained at rest or under stress,
e calculated the total area of the perfusion defect
nd the index of the perfusion defect, defined as the
roduct of the area by the mean intensity of the
efect. A global reversibility index was calculated
or each patient by subtracting the indexes obtained
n the stress-rest images.
For analysis of the topographic correlation of
hanges in perfusion, and for serial myocardial
erfusion imaging evaluation, the polar maps were
isually assessed by 2 experienced observers and the
iscordances solved by consensus. The segments oxhibiting an uptake defect on at least two-thirds of
heir surface were defined as having an uptake
efect. The segments presenting an uptake defect in
he images of the stress phase, but not in the images
f the rest phase, were defined as having a reversible
efect.
chocardiographic study. The examinations were
arried out by trained echocardiographers and
tored as high-resolution VHS images. The initial
nd late examinations were analyzed off-line by a
ingle experienced echocardiographer who was
linded regarding clinical and scintigraphic data, as
ell as to the phase of the study.
Images of sections on the long and short
arasternal axes and apical 2- and 4-chamber views
ere obtained. Global systolic function of the left
entricle was evaluated by calculation of the ejection
raction (EF) in the apical 2- and 4-chamber
ections by the method of Simpson. Segmental wall
otion was analyzed by dividing the left ventricle
nto 17 segments. A semiquantitative visual mobil-
ty score was attributed to each segment: 1 
ormal mobility, 2 hypokinesis, 3 akinesis, and
 dyskinesis. A segmental wall motion index for
he left ventricle was calculated for each patient as
he sum of the scores divided by the total number of
egments evaluated.
tatistical analysis. Data are reported as mean 
D. The Kolmogorov-Smirnov test was used to
etermine whether the variables showed normal
istribution. For the comparison of the means
nd/or the determination of correlation between
ariables with non-normal distribution, we used the
onparametric Wilcoxon matched-pairs signed-
anks and Spearman rank correlation tests, respec-
ively. For variables with normal distribution, we
sed the paired t test and the Pearson correlation
est. Fisher’s exact test was used to test the topo-
raphic association between LV regional function
nd perfusion changes. The level of significance was
et at p  0.05 in all analyses.
E S U L T S
able 1 presents the general demographic, clinical,
nd laboratory characteristics of the patients at the
ime of the first and final evaluations.
valuation of LV function. Left ventricle ejection
raction (LVEF) evaluated by 2-dimensional echo-
ardiogram showed a significant reduction between
he initial (55.0  11.0%) and the late examination
50.0  13%; p  0.0001, Wilcoxon test). Analysis
f segmental wall motion in the initial study re-
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167ealed that 23 (64%) patients had dysynergy in at
east 1 regional segment of the left ventricle. Of the
12 segments analyzed, 172 (28%) presented dysyn-
rgy, 128 hypokinetic, 31 akinetic, and 13 dyski-
etic, with a mean of 4.8 abnormal segments per
atient. The mean initial segmental wall motion
ndex was 1.4  0.39.
In the late analysis, 27 patients (75%) pre-
ented dysynergy in at least 1 LV regional seg-
ent. A total of 248 dysynergic segments were
etected among the 612 segments analyzed
40.5%), with a mean of 6.9 abnormal segments
er patient. Of these, 171 presented hypokinesis,
6 akinesis, and 11 dyskinesis. Thus, the mean
ndex of segmental wall motion was 1.5  0.48 in
Table 1. Demographic, Clinical, and Laboratory Characteristics
of the Patients (n  36) at the Time of Initial and Late
Myocardial Perfusion SPECT and Echocardiographic Evaluations
Initial
Evaluation
Late
Evaluation
Sex, male 17 (47%) 17 (47%)
Age, yrs 57  10 63  10
Symptoms
Dyspnea 16 (44%) 14 (39%)
Precordial pain 25 (69%) 9 (25%)*
Palpitations 12 (33%) 5 (14%)*
Dizziness 6 (17%) 5 (14%)
NYHA functional class
I 27 (75%) 26 (72%)
II 6 (17%) 8 (22%)
III 2 (5%) 2 (5%)
IV 1 (3%) 0
Resting electrocardiogram
Left anterior hemiblock 11 (31%) 13 (36%)
Right bundle branch block 14 (39%) 16 (44%)
Left bundle branch block 2 (5%) 2 (5%)
Ventricular ectopic beat 7 (19%) 4 (11%)
Atrial ﬁbrillation 4 (11%) 4 (11%)
Pacemaker 7 (19%) 17 (47%)*
Inactive electric zone 2 (5%) 2 (6%)
Medications
Acetylsalicylic acid 7 (19%) 11 (31%)
Amiodarone 8 (22%) 14 (39%)*
Calcium-channel antagonist 2 (5%) 0
Beta-blocker 6 (17%) 18 (50%)*
Digitalis 1 (3%) 5 (14%)
Diuretics 9 (25%) 14 (39%)*
ACE inhibitor 19 (53%) 26 (72%)*
Nitrates 2 (5%) 3 (8%)
*p  0.05 for comparison with the initial evaluation (paired proportion test).
ACE  angiotensin-converting enzyme; NYHA  New York Heart Associa-
tion; SPECT  single-positron emission computed tomography.he late evaluation, corresponding to a significantncrease compared to the initial evaluation (p 
.0003, Wilcoxon test).
The topographic distribution of left ventricle
egments showing dysynergy and perfusion abnor-
alities in the initial and late study is presented in
able 2. It can be seen that the appearance of new
all motion defects predominated in the apical
egion and in the inferior and inferolateral walls of
he left ventricle.
erfusion defects at rest. Uptake defects at rest were
dentified in 27 of the 36 (75%) patients in the
nitial study and in 28 of the 36 (77.8%) in the late
tudy. Of the 612 segments analyzed, 98 (16%)
resented perfusion defects at rest in the initial
tudy, and 158 (25.8%) presented defects in the late
tudy. The topographic distribution of the segments
xhibiting a perfusion defect at rest is also shown in
able 2. A predominant involvement of the infero-
ateral, inferior, and apical walls of the left ventricle
as observed.
A significant increase in the index of uptake
efect (incorporating area and severity) at rest was
bserved between the initial study (5.5 5.2%) and
he late study (9.3  8.3%; p  0.0013, Wilcoxon
est). The same behavior was detected when the
reas of the defects at rest were compared between
he initial study (18.8  14.1%) and the late study
26.5  19.1%; p  0.0075, paired t test).
Table 2. Frequency Distribution of the Left Ventricular Segmen
Motion and Perfusion Disorders According to a 17-Segments M
Segments
Alteration of
Parietal Mobility
Initial
Reversible
Perfusion
DefectInitial Late
Basal anteroseptal 5 6 0
Basal anterior 3 5 0
Basal anterolateral 11 11 2
Basal inferolateral 15 20 5
Basal inferior 22 21 5
Basal inferoseptal 12 13 0
Mid-anteroseptal 3 8 2
Mid-anterior 5 7 2
Mid-anterolateral 8 10 1
Mid-inferolateral 15 21 7
Mid-inferior 12 17 5
Mid-inferoseptal 5 12 2
Apical septal 9 19 3
Apical anterior 11 19 1
Apical lateral 12 18 3
Apical inferior 13 19 3
Apex 11 22 6ts Showing Wall
odel
Perfusion
Defect at Rest
Initial Late
0 1
0 0
1 5
13 20
7 17
0 4
0 1
0 1
2 2
10 18
7 17
1 1
5 7
4 8
12 13
19 23
17 20Total 172 248 47 98 158
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168eversible perfusion defects. In the initial scinti-
raphic study, reversible perfusion defects were
etected in 20 (56%) patients, involving 47 of 612
egments (7.6%). The topographic distribution of
he frequency of segmental involvement is summa-
ized in Table 2.
Considering the subgroup of 20 patients who
xhibited reversible perfusion defects in the initial
tudy, a reduction of the reversibility index for the
Late perfusion defect index at rest
r=-0.7227
p=<0.0001
            5            10           15           20           25            30           35
Between Rest Perfusion Defect and LV Systolic Function
nstrates the signiﬁcant negative correlation between the perfu-
grating extent and severity) obtained by using myocardial perfu-
ission computed tomography imaging at rest and the
al value of the left ventricular (LV) ejection fraction assessed by
rdiogram (R  0.7227; p  0.0001, Spearman correlation test).
at in patients with chronic Chagas’ cardiomyopathy, the degree
ion correlates with the extent/severity of the perfusion defect at
rresponds to areas of regional myocardial ﬁbrosis.
Variation of the perfusion defect index at rest
-2            2              6            10           14           18           22
r=0.4211
p=0.0105
Between Changes of Rest Perfusion Defects and LV Function
ates the signiﬁcant positive correlation between the increase in
defect at rest and the degree of left ventricular (LV) ejection frac-
d between the initial and late evaluations (R  0.4211; p 
tion test). This result indicates that the progression of global LV
with the aggravation of the extent and severity of perfusionp
y signaling the increase in the areas of myocardial ﬁbrosis.erfusion defects was observed between the initial
tudy (3.4  3.1%) and the late study (1.5  2.4%;
 0.044, Wilcoxon test). The same result was
btained when the reduction of the area of revers-
ble defects was compared between the initial study
10.2  9.7%) and the late study (3.19  10.9%;
 0.012, Wilcoxon test).
orrelation between changes in myocardial perfusion
nd LV systolic function. A significant topographic
ssociation was observed between the presence of
erfusion defects and segmental wall motion
bnormalities at the late scintigraphic and echo-
ardiographic studies. Of the 178 segments ex-
ibiting perfusion defects, 128 (72%) presented
hanges in regional mobility, whereas of the 434
egments without perfusion defects, only 120
28%) had wall motion abnormalities (p 
.0001, Fisher exact test). Additionally, a signif-
cant negative correlation was observed between
he index of perfusion defects at rest detected in
he final scintigraphic study and the correspon-
ent LVEF (R  0.7227; p  0.0001, Spear-
an correlation test) (Fig. 1).
Regarding the progression of perfusion and func-
ion changes, a significant positive correlation was
bserved between the increase in the index of
erfusion defect at rest and the reduction of LVEF
etween the 2 evaluations (R  0.4211; p 
.0105, Pearson correlation test) (Fig. 2).
ssociation between reversible perfusion defects and
rogression of myocardial uptake defects at rest. A
igher frequency of new perfusion defects at rest
n the late study was seen in the segments
xhibiting reversible defects in the initial study.
f the 47 segments presenting reversible perfu-
ion defects in the initial study, 32 (68%) pro-
ressed to perfusion defects at rest, and of the 469
egments not showing reversibility in the initial
tudy, only 41 had the same progression (8.7%; p
0.0001, Fisher exact test). An illustrative
xample of a patient of this series, presenting
eversible perfusion defects in the initial myocar-
ial perfusion study topographically correlated to
he region of rest perfusion defect in the final
valuation, is displayed in Figure 3.
ther correlations. No significant correlation was
ound between the initial stress or rest scores and
he deterioration of LV function over time. Neither
as any correlation found between perfusion defect
cores and the tracer used. Finally, no differences
ere observed in the topographic distribution ofL
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169I S C U S S I O N
erfusion defects at rest and progression of systolic
ysfunction. The correlation between perfusion de-
ects at rest and myocardial fibrosis has been de-
cribed in patients with dilated cardiomyopathy
tudied with endomyocardial biopsies or through
utopsy investigations (11). Previous findings from
ur laboratory showed that chagasic patients with
ngiographically normal coronary arteries had fixed
erfusion defects at planar thallium-201 stress-rest
yocardium scintigraphy in left ventricle segments
ith severe dysynergy (akinesis or dyskinesis), pos-
ibly denoting the presence of cardiac fibrosis (9). In
nother observational cross-section study, we used
PECT thallium-201 scintigraphy for the evalua-
ion of 37 patients in various stages of Chagas’ heart
isease and demonstrated perfusion defects (fixed,
aradoxical, or reversible) in 78% of the patients. In
his later investigation, the extent of the perfusion
efects at rest correlated with the degree of LV
ystolic dysfunction (10). With the present study,
e provide the first longitudinal observation in
Figure 3. Stress and Redistribution Polar Maps of Initial and La
Stress and redistribution polar maps of the initial (A) and late (B) si
myocardial perfusion study of a patient enrolled in the study. The i
fraction at the time of the initial study was 36% and declined to 31
perfusion defect involving the apex, septal, inferoseptal, inferior, an
extensive rest perfusion defect is observed in the same topographyatients with CCC showing that the progression of toth segmental and global LV dysfunction corre-
ates with the aggravation of the extent and severity
f perfusion defects at rest, possibly signaling the
ncrease in the areas of myocardial fibrosis.
These results agree with pathology studies on
uman hearts showing that myocardial fibrosis is a
ost prominent histopathological feature of CCC
hat is correlated with the degree of impairment of
ardiac function (12). Also, a recent study using
agnetic resonance imaging showed in vivo evi-
ence of more marked myocardial fibrosis in more
dvanced forms of chagasic cardiomyopathy (13).
Even though a significant association was
ound between the temporal reduction in LVEF
nd the concomitant increase of regional myocar-
ial fibrosis, the correlation between these vari-
bles was not strong (R  0.42) (Fig. 2). This
robably reflects the effect of other determinants
f progression of LV dysfunction, besides coales-
ence of regional fibrosis, such as active diffuse
ocal myocarditis (14).
eversible perfusion defects. In the present study,
PECT Thallium-201 Myocardial Perfusion Studies
-positron emission computed tomography (SPECT) thallium-201
val between images was 6.5 years. The left ventricular ejection
t the late evaluation. A large, predominantly reversible myocardial
ferolateral walls is seen in the initial study. In the late study, ante S
ngle
nter
% a
d inhe initial myocardial perfusion SPECT scans dem-
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170nstrated reversible perfusion defects in a large
roportion of patients (55%) in the absence of
ngiographically significant obstructive epicardial
oronary disease. This finding suggests that revers-
ble myocardial ischemia in those patients is due to
isorders at the level of the coronary microcircula-
ion (15) and confirms previous studies of Chagas’
eart disease that reported similar findings (8–10).
However, this is the first time that a topo-
raphic correlation was found between reversible
erfusion defects and the later appearance of new
erfusion defects at rest that correlated with
eterioration of segmental and global systolic LV
ysfunction. This observation strongly suggests a
orrelation between disorders in the coronary
icrocirculation and the progression of regional
yocardial fibrosis, as previously postulated from
xperimental and human pathology evidence.
hus, autopsy studies have reported diffuse col-
apse of intramyocardial arterioles, with luminal
onstriction attributed to intimal proliferation
4). Notably, these microvascular abnormalities
orrelated topographically with the extension of
iffuse myocytolysis and myocardial fibrosis.
lso, studies of biopsy specimens showed exten-
ive microvascular abnormalities, including thick-
ning of the basal capillary membrane (16).
bnormal vasodilation and vasoconstriction pat-
erns at the microcirculatory level have been
mplicated as causing myocardial damage in pa-
ients with Chagas’ disease (17). Finally, studies
n the experimental murine model of Chagas’
isease have demonstrated microcirculatory dis-
rders such as formation of occlusive platelet
hrombi in the epicardiac and small intramural
oronary arteries, leading to myocardial ischemia
etectable by histochemical methods in vivo (6).
he mechanisms responsible for the formation of
cclusive platelet thrombi and microcirculatory
pasm include injury to endothelial cells by T.
ruzi infection (18), increased local production of
ndothelin and thromboxane-A2 by the infected
issue, and increased production of cytokines by
he chronic inflammatory infiltrate, leading to
bnormal microvascular reactivity (19).
It is worth emphasizing that microvascular
oronary dysfunction is not a particular feature of
hagas’ cardiomyopathy, as it has also been
ecognized in patients with ventricular dysfunc-
ion caused by dilated cardiomyopathy due to
ther causes (20,21). In an even more relevant
anner, it has been demonstrated that the degreef microvascular coronary dysfunction is an inde- cendent predictor of cardiac events in patients
ith dilated cardiomyopathy, being associated
ith an increased risk of death and with addi-
ional progression of heart failure (22,23). The
rognostic implications of coronary microvascu-
ar dysfunction for CCC await confirmation by a
rospective study specifically designed to assess
hat hypothesis.
athophysiologic implications. It is plausible to as-
ume that, similar to obstructive epicardial coronary
rtery disease, repeated ischemic phenomena in
hronic Chagas’ heart disease may cause myocyto-
ytic necrosis with consequent coalescent cicatricial
njuries related to the areas of regional transmural
brosis identified during the more advanced phases
f CCC.
We can also speculate that repeated ischemic
vents in chronic Chagas’ heart disease may cause
ransient regional LV contractile dysfunction due
o a phenomenon of myocardial stunning, with
ate development of persistent contractile dys-
unction similar to hibernating myocardium (24).
his mechanism can explain the observation of
egmental wall motion impairment in left ventri-
le regions with ischemic viable myocardium in
CC patients and normal coronary arteries (10).
his hypothesis is compatible with preliminary
tudies showing improved LV function in pa-
ients with Chagas’ disease acutely treated with
sosorbide dinitrate (25) and taking dipyridamole
or prolonged periods of time (26). In those
tudies, however, no clear relation was demon-
trated between improvement of LV function and
elief of myocardial ischemia.
Finally, the elucidation of the mechanism me-
iating the regional LV wall motion and perfu-
ion changes needs further studies, mainly corre-
ating these findings with histopathological
bservations.
tudy limitations. In the present study, the assess-
ent of the LV myocardial perfusion and wall
otion were performed by using 2 different imag-
ng techniques. This may have caused some degree
f topographic mismatch during the analysis. A
imultaneous evaluation of LV perfusion and func-
ion by using gated SPECT imaging would have
ircumvented this problem.
Because both thallium-201 and sestamibi labeled
ith technetium-99m were used for the studies of
yocardial perfusion in various patients, to correct
or possible differences between these radiopharma-
euticals in the detection of perfusion abnormali-
t
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171ies, quantitative analyses based on polar maps and
omparisons with normal data bases were made.
Even though obstructive coronary artery disease
as excluded in the patients presenting reversible
erfusion defects in the initial evaluation, we cannot
xclude entirely that coronary artery disease may
ave developed in a patient during the follow-up
eriod.
O N C L U S I O N S
his is the first study to observe and correlate
ongitudinal changes of both myocardial perfusion
nd LV wall motion abnormalities in the same
roup of patients with CCC followed up for a
ignificant period of time. On the basis of theabnormalities in chronic Chagas’ dis- Am J Cardiol 1988est was clearly correlated with the progression of
V systolic dysfunction. In addition, reversible
erfusion defects detected at the initial evaluation
ere topographically correlated with the develop-
ent of new perfusion defects at rest at the later
tudy, indicating the installation of new areas of
brosis, as the disease progresses in patients with
ngiographically normal coronary arteries. These
esults lend support to the notion that regional
bnormalities of LV perfusion, possibly caused by
icrovascular derangements, participate in the
athogenesis of myocardial damage in CCC.
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